chrisvoncsefalvay/vaers-outcomes huggingface dataset:
fever; arm pain; headache; This spontaneous case was reported by an other caregiver and describes the occurrence of PYREXIA (fever), PAIN IN EXTREMITY (arm pain) and HEADACHE (headache) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever), PAIN IN EXTREMITY (arm pain) and HEADACHE (headache). At the time of the report, PYREXIA (fever), PAIN IN EXTREMITY (arm pain) and HEADACHE (headache) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant drugs were not provided treatment drugs were not provided.
did not feel like herself; right arm itchiness; could not do anything; felt exhausted; sore right arm; had no energy; feel like she had acovid again; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore right arm), ASTHENIA (had no energy), MALAISE (could not do anything), DEREALISATION (did not feel like herself) and PRURITUS (right arm itchiness) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in November 2020. Concurrent medical conditions included Blood pressure abnormal, Blood cholesterol abnormal and Thyroid activity decreased. Concomitant products included SERTRALINE and INSULIN for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore right arm), ASTHENIA (had no energy), FEELING ABNORMAL (feel like she had acovid again), PYREXIA (fever) and CHILLS (chills). On 06-Feb-2021, the patient experienced MALAISE (could not do anything) and FATIGUE (felt exhausted). On an unknown date, the patient experienced DEREALISATION (did not feel like herself) and PRURITUS (right arm itchiness). The patient was treated with PARACETAMOL (TYLENOL) 05-Feb-2021 at an unspecified dose and frequency. On 07-Feb-2021, FEELING ABNORMAL (feel like she had acovid again), CHILLS (chills) and FATIGUE (felt exhausted) had resolved. On 08-Feb-2021, ASTHENIA (had no energy) and MALAISE (could not do anything) had resolved. At the time of the report, PAIN IN EXTREMITY (sore right arm) and PRURITUS (right arm itchiness) had not resolved, DEREALISATION (did not feel like herself) outcome was unknown and PYREXIA (fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2021, Body temperature: inconclusive (Inconclusive) Inconclusive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Headache, nausea, fever, chills, soreness in right arm, and insomnia. No treatment provided. Symptoms ongoing as of 9:45am 03/23/2021
17AUG91 cranky, faint rash during day @ 7PM t104 R, called MD, also had runny nose, watery eyes, APAP & alcohol bath/ice baths til Monday evening 19AUG91; Rash was faint until 21AUG91 when it became bright red & blotchy over entire body;
Shooting Pain down arm to finger tips. Diagnosis - frozen shoulder. 11/21/17 Flu vaccine administered in high left shoulder by pharmacist. I had shooting pain all the way down my arm to my finger tips upon vaccine administration. 12/17/17 I made call to pharmacist reporting continued and worsening left shoulder pain since vaccine administration. Reported I would be seeking medical care since all attempts with pain meds and icing had not resolved pain. Being an RN and having managed the vaccine program for a local public health department, I was familiar with VAERS reporting and suggested this be done. Pharmacist said she was from another location but would have someone call me. 12/19/17 Received call from Pharmacist. Explained my situation and she said to let them know medical information after my orthopedic appt. 12/20/17 Seen by PA at Orthopedic. Diagnosis: tendonitis from improperly administered vaccine. Shoulder xray done. Steroid injection given. To return if no improvement in 2-4 weeks. 1/9/18 Returned to Orthopedic due to continued L shoulder pain and limited range of motion. Seen by Dr. Diagnosis: adhesive capsulitis (frozen shoulder). Recommended steroid injection into different shoulder space than previous injection. Also, recommended physical therapy. 1/15/18 Steroid injection given by Dr. 1/24/18 Will begin physical therapy appts. 4 set up for initial treatment. Medical records have been requested.
Severe fatigue; Myalgia; Head aches; Weakness; This is a spontaneous report from a contactable other hcp reporting for himself.   This 33-year-old male patient received the first dose of bnt162b2 (BNT162B2), intramuscular at single dose in the left arm on 16Dec2020 12:00 at hospital for immunisation.  Medical history included atypical cluster headaches. Concomitant medication included docusate sodium (COLACE), verapamil and vitamin D3. On 16Dec2020 18:00, the patient experienced severe fatigue, myalgia, head aches, weakness. No treatment required. The  outcome of the events was recovering. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19.   Information on the lot/batch number has been requested.
Temperature between 99 to 100, constant vomiting and diarrhea for ~10 hours (diarrhea still on-going), muscle aches, joint aches, headache
No symptoms other than minor sore for a day.  Otherwise I have been fine since the vaccination.
Tdap received on 4/23/12 erythema noted on 4/28/12 and spread. She has erythema, warmth & tenderness at site. Treated with BACTRIM DS BID x 10 days & warm compresses - cellulitis.
Headache, Myalgia, Arthralgia, Fever, NauseaVomiting SEVERE LEG AND WRIST PAIN, LEGS SO WEAK COULD NOT WALK Narrative:
lost his sense of taste; lost his sense of smell; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Aug-2021 and was forwarded to Moderna on 09-Aug-2021.    This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (lost his sense of taste) and ANOSMIA (lost his sense of smell) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048B21A and 006B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced AGEUSIA (lost his sense of taste) and ANOSMIA (lost his sense of smell). At the time of the report, AGEUSIA (lost his sense of taste) and ANOSMIA (lost his sense of smell) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Jul-2021, SARS-CoV-2 test: positive (Positive) Tested positive for COVID-19.         No concomitant medication were reported. No treatment medication were reported.
Received HPV #1 vaccine  9/13/07.  Mother called on 10/29/07 stating since vaccine given, child's "mental state altered greatly.  All of a sudden she became this witch."  Since then "she became very aggressive and almost pouty in every situation".  She states that the child hit her (the mother) last Wednesday or Thursday. Mother states that since the shot the child "has become aggressive, dark, argumentative".  She further states that since the shot the child has become "mouthy to the teachers".  She has always been a "spirited child" according to the mother.  Mother now states that the child seems to be calming down some.  I offered to submit a VAERS report and mother agreed that I should do so.
After minutes of vaccine administration, she felt dizz, was paley and pressure in the chest, for around 15 minutes. We provide alcohol pads and call 911 because symptos and signs.
After first dose severe headache for two days with some dizziness.  After second dose sleepless that night then around 4AM chills and hot flashes with sweating, got up to walk around and had shortness of breath, teeth chattering, slept most of Friday had aches, headache, nausea.. had to concentrate on not vomiting, heightened sense of smell,  had 101.7. Saturday initially felt ok the terrible headache and nausea, achey and still 101.7 temp. Sunday initially felt good and then with the headache, nausea, shortness of breath, achey,  101.7 temp.  Monday felt ok all day until around 5pm and then chest hurt and shortness of breath.
Pt was anxious prior to the vaccine administration; became dizzy, pale ,clammy, weakness. Evaluated by paramedic, HR increased to 134, no shortness of breath or tingling/numbness noted. Paramedic called, patient declined, called brother to take her to her apartment, agreed to keep an eye on her.
Developed immediate fever & cills within 2 hours. By next morning had pain & difficulty producing urine.  Saw primary care doctor and urgent care center, infection not treated w/PO Macrobid after 2 days.  Admitted to Hospital w/sepsis, kidney infection and acute renal injury?creatinine 4.25 (baseline=1.5)
Chief Complaint: Cough and shortness of breath Additional Medical History:  Patient is a 78-year-old male with a history of coronary artery disease, asthma, COPD, arthritis and depression.  He presented to the emergency room by EMS complaining of worsening cough and shortness of breath over the last 3 days.  Patient states 3 days ago he developed a cough which has progressively become worse.  He states the cough is productive at times of yellowish colored sputum.  He feels short of breath especially with seen when he is coughing or moving around.  He denies fever or chills or sick contacts with similar symptoms.  The shortness of breath became significant just prior to arrival at which point he called EMS.  EMS arrived on the scene to find the patient hypoxic at 85% on room air.  He was transported to the hospital.  On 2 L nasal cannula he is oxygenating at 93 to 95%.  He is otherwise alert and appropriate.  He is in mild distress on presentation.  He denies any chest discomfort or swelling of his lower extremities.  He quit smoking 25 years ago. Associated Symptoms: cough, depression, fatigue, palpitations, shortness of breath, sputum, weakness, wheezing
Symptoms were mild the first few days then went away. Fatigue, nausea, and feeling of something stuck in throat. On day 7 there was extreme fatigue, nausea, and a huge drop in blood sugar. This then progressed into severe back pain and difficulty breathing. Treatment was 3 days in ICU and 4 days in a recovery room where multiple there were numerous tests administered along with numerous medications administered. 24 dialysis was performed. Outcome was Metformin induced metabolic acidosis with renal failure and severely acidic.
No Adverse Event; Inappropriate schedule of vaccine administered; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) and NO ADVERSE EVENT (No Adverse Event) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for Plaque psoriasis.    Concurrent medical conditions included Plaque psoriasis.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In 2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) at an unspecified dose. On 20-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse Event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.            It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   This case was linked to MOD-2021-621183 (Patient Link).
Pt came in & showed bruise on upper left shoulder c/c difficulty raising & moving the arm. Complaint of shoulder bone pain. RPh on duty recommended warm moist head and BENGAY when not using heat.
Breakthrough COVID on May 1, 2022; COVID rebound after Paxlovid on May 13, 2022
Chief Complaint Patient presents with ABDOMINAL PAIN Pt reports right sided abd pain almost to right flank area since last night     with urinary frequency and soft stools x 2 days HPI Per patient during my interview:   Patient presents emergency department as noted above.  Patient with right-sided flank and abdominal pain since last night.  Patient notes lately evening and kept her up most of the night.  Notes she had difficulty sleeping or finding a position of comfort due to discomfort.  Had to lay on her left side.  Reports pain persistent mainly when taking a deep breath.  Also somewhat tender in the right upper quadrant.  No nausea or vomiting.  No fevers or chills.  No lower abdominal pain.  Denies any urina HPI Per patient during my interview:   Patient presents emergency department as noted above.  Patient withm right-sided flank and abdominal pain since last night.  Patient notes lately evening and kept her up most of the night.  Notes she had difficulty sleeping or finding a position of comfort due to discomfort.  Had to lay on her left side.  Reports pain persistent mainly when taking a deep breath.  Also somewhat tender in the right upper quadrant.  No nausea or vomiting.  No fevers or chills.  No lower abdominal pain.  Denies any urinary complaints.  No vaginal complaints.  No recent cough or URI symptoms.  She works from home and denies any Covid contacts.  No prior history of gallstones or kidney stones.  She states she is uncomfortable however denies having taking any medicine at home.  Has had normal bowel movements and did so this morning.  Did not relieve her pain.  Felt like she had trapped gas.  Denies alcohol.  She is otherwise in her baseline health.  Physical exam: Constitutional:  BP 126/46  | Pulse 75  | Temp 98.6 °F (37 °C)  | Resp 18  | Ht 1.6 m (5' 3")  | Wt 91.6 kg (201 lb 15.1 oz)  | SpO2 96%  | BMI 35.77 kg/m²  No acute distress.  Does not appear ill.  Speaking clear and coherent sentences.  Pleasant and articulate.   No cause was found.  No treatment was provided.  The pain slowly went away on its own over several days.
Twinrix was given on 27Dec2020 and 2nd dose not administered; had a second dose with Engerix-B instead; This case was reported by a nurse via call center representative and described the occurrence of incomplete course of vaccination in a 60-year-old female patient who received HAB (Twinrix) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis and HBV (Engerix B) for prophylaxis.   Previously administered products included Twinrix (1st dose received on 27th December 2020 batch 75C72  expiry date 13th June 2022).   On an unknown date, the patient received the 2nd dose of Twinrix and Twinrix Pre-Filled Syringe Device. On 20th April 2021, the patient received Engerix B. On 20th April 2021, not applicable after receiving Twinrix and Twinrix Pre-Filled Syringe Device and unknown after receiving Engerix B, the patient experienced wrong vaccine administered. On an unknown date, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination and wrong vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were reported as follows: The age at the time of Engerix B vaccination was not reported but it could be 59 years or 60 years. The age at vaccination was not applicable for Twinrix. After having 1st dose, the patient did not receive next dose of the Twinrix, which led to incomplete course of vaccination. The patient got 2nd dose with Engerix-B instead, which led to wrong vaccine administered. The reporter asked guidance on how to proceed on the completion of Twinrix dosing schedule. No other information was collected. The reporter consent to follow up.
RIGHT EYE STARTED TO BE SWELLING; FACE STARTED TO BE A LITTLE SWELLING/SEMI-FALLEN FACE; WHOLE BODY STARTED TO BE SWELLING; ITCHY FROM SCALP TO TOES; SEVER STOMACH PAIN; This spontaneous report received from a consumer concerned a 72 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included asthma. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported ,batch number: 207A21A expiry: UNKNOWN) dose was not reported, administered on 17-JUL-2021 for prophylactic vaccination. No concomitant medications were reported.  On 17-JUL-2021, the subject experienced sever stomach pain. On 20-JUL-2021, the subject experienced right eye started to be swelling. On 20-JUL-2021, the subject experienced face started to be a little swelling/semi-fallen face. On 20-JUL-2021, the subject experienced whole body started to be swelling. On 20-JUL-2021, the subject experienced itchy from scalp to toes. Treatment medications (dates unspecified) included: diphenhydramine hydrochloride, and famotidine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sever stomach pain, and itchy from scalp to toes, and was recovering from right eye started to be swelling, face started to be a little swelling/semi-fallen face, and whole body started to be swelling. This report was non-serious.; Sender's Comments: V0: Medical assessment comments not required as per the standard procedure as the case is assessed as non-serious.
This patient tested positive for COVID on 7/7/2021. Received dose #1 Moderna 12/26/2020, dose #2 Moderna 1/20/2021
Patient received ZOSTAVAX in right arm, subcutaneous on 10/10/11. On 10/12/11, started with swelling, blisters, itch, painful and redness. Spoke with Dr during appt. Clindamycin 300mg ordered 4 times a day for 7 days.
Vaccinia contact transmission: Brother vaccinated for smallpox on 2/22/06. He wrestled with no shirts on with other person on 3/3/06. Lesion developed wrist, 2 on face, one on back on 3/6/06. Has subsequent contact with girlfriend on  3/7 - she "pinched" lesions on his wrist. 3/14 - She developed lesion on face.
Headache today; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache today) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced HEADACHE (Headache today). At the time of the report, HEADACHE (Headache today) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Acute pericarditis; Severe pleuritic chest pain; Severe pleuritic chest pain; This is a spontaneous report received from contactable reporter(s) (Physician). The reporter is the patient.  A 74-year-old male patient received BNT162b2 (BNT162B2), as dose 4 (booster), single (Lot number: Fk9893) at the age of 74 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Cad" (unspecified if ongoing), notes: Cad; "dm" (unspecified if ongoing), notes: dm; "HTN" (unspecified if ongoing), notes: HTN; "DMD" (unspecified if ongoing), notes: DMD; "dyslipidemia" (unspecified if ongoing); "gerd" (unspecified if ongoing), notes: gerd. Concomitant medication(s) included: METFORMIN; REPATHA; GLYBURIDE; COREG; AMLODIPINE; OLMESAB. Vaccination history included: Bnt162b2 (Dose 3:, Lot number: Fd0810, Vaccine location: LT arm), for COVID-19 immunization; Bnt162b2 (Dose 2:, Lot number: El1284, Vaccine location: LT arm), for COVID-19 immunization; Bnt162b2 (Dose 1:, Lot number: Ek5730, Vaccine location: LT arm), for COVID-19 immunization. The following information was reported: PERICARDITIS (medically significant) with onset 23May2022 at 09:00, outcome "recovering", described as "Acute pericarditis"; PLEURITIC PAIN (medically significant), CHEST PAIN (medically significant) all with onset 23May2022 at 09:00, outcome "recovering" and all described as "Severe pleuritic chest pain". The events "acute pericarditis" and "severe pleuritic chest pain" required physician office visit and emergency room visit. Therapeutic measures were taken as a result of pericarditis, pleuritic pain, chest pain. Clinical course included treatment received for the adverse event was Colchicine and naprosyn. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19; Sender's Comments: Based on the information currently available, a possible contributory role of the suspect drug BNT162b2  to all the reported events Pericarditis , Pleuritic pain, Chest pain  cannot be completely excluded based on temporal association and known drug safety profile
systemic reaction characterized by malaise, headache, no fever, and diffuse erythematous papules to torso
The pt developed severe fever, chills 3 weeks after vaccines followed by neuritis and peripheral neuropathy in left arm and paralysis of left thumb and index finger. Annual follow up states patient's strength in thumb and index finger at about 50%. Continued pain in forearm and muscle loss near wrist.
Diarrhea started about two weeks after second dose Covid  Pfizer vaccine has not resolved no change in diet or medications.